LEAST as a novel prediction model of hepatocellular carcinoma development in patients with chronic hepatitis B: a multi-center study
The LEAST model could predict HCC development in CHB patients, facilitating the identification of high-risk patients who might benefit from enhanced surveillance or early therapy.
Authors
- Zhigang Ren (ORCID: https://orcid.org/0000-0003-0798-3444)
- Jingjing Song (ORCID: https://orcid.org/0000-0002-2026-8755)
- Xiaoqing Wu (ORCID: https://orcid.org/0000-0003-2651-6112)
- Qiuling Wang (ORCID: https://orcid.org/0000-0002-1066-5909)
- Fajuan Rui (ORCID: https://orcid.org/0009-0006-4895-2248)
- Zuxiong Huang (ORCID: https://orcid.org/0000-0003-0994-0384)
- Jie Li (ORCID: https://orcid.org/0000-0003-2343-1658)
- Jinhua Shao
- Yuemin Nan (ORCID: https://orcid.org/0000-0003-4192-099X)
- Xiaoxiao Zhang (ORCID: https://orcid.org/0000-0002-0312-7205)
- Chao Sun (ORCID: https://orcid.org/0000-0001-7222-4028)
- Yang Zhou (ORCID: https://orcid.org/0000-0002-7213-2518)
- Wen Xie
Institutions
- Hebei Medical University (CN)
- Fujian Medical University (CN)
- Capital Medical University (CN)
- Tianjin Medical University General Hospital (CN)
- Third Hospital of Hebei Medical University (CN)
- Hospital of Hebei Province (CN)
- Nanjing Drum Tower Hospital (CN)
- Mengchao Hepatobiliary Hospital (CN)
- Hebei Seismological Bureau (CN)
- Beijing Ditan Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Hebei Science and Technology Department (CN)
- Medical Technologies (Czechia) (CZ)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1186/s12916-025-04430-2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hebei Provincial Key Research Projects